deltatrials
Completed OBSERVATIONAL NCT05434923

PORTHOS - PORTuguese Heart Failure Observational Study (PORTHOS)

PORTHOS - PORTuguese Heart Failure Observational Study: a Nationwide Epidemiological Study on Heart Failure and Asymptomatic Left Ventricle Systolic Dysfunction Based on Contemporary Diagnostic Tools

Sponsor: AstraZeneca

Conditions Heart Failure
Updated 18 times since 2022 Last updated: Aug 23, 2024 Started: Jun 30, 2022 Primary completion: Sep 18, 2023 Completion: Sep 18, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Heart Failure and is currently completed. AstraZeneca leads this study, which shows 18 recorded versions since 2022 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshot~Nov 2022 – ~Dec 2022 · 30 days · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Feb 2023 · 31 days · monthly snapshot~Feb 2023 – ~Mar 2023 · 28 days · monthly snapshot~Mar 2023 – ~Apr 2023 · 31 days · monthly snapshot~Apr 2023 – ~May 2023 · 30 days · monthly snapshot~May 2023 – ~Jun 2023 · 31 days · monthly snapshot~Jun 2023 – ~Jul 2023 · 30 days · monthly snapshot~Jul 2023 – ~Aug 2023 · 31 days · monthly snapshot~Aug 2023 – ~Sep 2023 · 31 days · monthly snapshot~Sep 2023 – ~Oct 2023 · 30 days · monthly snapshot~Oct 2023 – ~Nov 2023 · 31 days · monthly snapshot~Nov 2023 – ~Jul 2024 · 8 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

18 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Nov 2023 — Jul 2024 [monthly]

    Completed

    Status: Recruiting → Completed

  5. Oct 2023 — Nov 2023 [monthly]

    Recruiting

▶ Show 13 earlier versions

  1. Sep 2023 — Oct 2023 [monthly]

    Recruiting

  2. Aug 2023 — Sep 2023 [monthly]

    Recruiting

  3. Jul 2023 — Aug 2023 [monthly]

    Recruiting

  4. Jun 2023 — Jul 2023 [monthly]

    Recruiting

  5. May 2023 — Jun 2023 [monthly]

    Recruiting

  6. Apr 2023 — May 2023 [monthly]

    Recruiting

  7. Mar 2023 — Apr 2023 [monthly]

    Recruiting

  8. Feb 2023 — Mar 2023 [monthly]

    Recruiting

  9. Jan 2023 — Feb 2023 [monthly]

    Recruiting

  10. Dec 2022 — Jan 2023 [monthly]

    Recruiting

    Status: Enrolling By Invitation → Recruiting

  11. Nov 2022 — Dec 2022 [monthly]

    Enrolling By Invitation

    Status: Recruiting → Enrolling By Invitation

  12. Sep 2022 — Nov 2022 [monthly]

    Recruiting

    Status: Not Yet Recruiting → Recruiting

  13. Jul 2022 — Sep 2022 [monthly]

    Not Yet Recruiting

    First recorded

Jun 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AstraZeneca
  • NOVA Medical School
  • Sociedade Portuguesa de Cardiologia
Data source: AstraZeneca

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aljustrel, Portugal , Aveiro, Portugal , Braga, Portugal , Castelo Branco, Portugal , Coimbra, Portugal , Lagos, Portugal , Lisbon, Portugal , Porto, Portugal , Serpa, Portugal , Setúbal, Portugal and 3 more locations